|
|
Current options for pharmacotherapy of anxiety and sleep disorders
Böhmová, Kateřina ; Vokřál, Ivan (advisor) ; Skálová, Lenka (referee)
Charles University in Prague Faculty of Pharmacy in Hradec Králové Department of Pharmacology & Toxicology Student: Kateřina Böhmová Supervisor: prof. MUDr. Hrdina Radomír, CSc., PharmDr. Bc. Kotolová Hana, Ph.D., PharmDr. Vokřál Ivan, Ph.D. Title of diploma thesis: Current options for pharmacotherapy of anxiety and sleep disorder Anxiety and sleep disorders belong to common medical conditions. Anxiety attacks are recurring unpleasant emotional states. Sleep disorders are characterized by an insufficient or excessive amount of sleep or its poor quality, which persist for a significant time period. These common disorders represent an important medical and socioeconomic problem. Opinions about etiopathogenesis and classification are constantly evolving. Complex treatment includes mostly removing the cause, lifestyle changes, psychotherapy, and pharmacotherapy. Antidepressants from SSRI or SNRI group are considered to be the drugs of the first choice in frequent anxiety disorders. The treatment of insomnia depends mainly on the type of disorder. Hypnotics should be reserved especially for short-term and transient forms of insomnia, the treatment of which must be started as soon as possible together with the cognitive component and the elimination of the primary cause of this insomnia. In the chronic...
|
|
|
Gut microbiota effect on neuropsychiatric diseases
Pospíšil, Vít ; Kostovčíková, Klára (advisor) ; Červená, Kateřina (referee)
The intestinal microbiome is formed by trillions of microorganisms that accompany us throughout our lives. Commensal gut microorganisms, as a complex system, interfere with diet processing and subsequent spectrum of released metabolites, which are involved in communication with other systems of the human body. Recently, a link between intestinal microbiota dysbiosis and activation of the immune response has begun to emerge. This pathophysiological condition is associated with the loosening of the tight junctions of the gut epithelial barrier, which could together with prolonged immune inflammation lead to what is known as irritable bowel syndrome. This disease is not only related to symptoms associated with bowel discomfort, but also to effects on afferent nerve endings. This connection has been called as the gut-brain axis and became the link between the gut microbiota and psychiatric diseases. This work is summing up the actual knowledge on this topic and offers a comprehensive overview of the subject from both an immunological and a microbiological point of view. Key words: gut-brain axis, depression, anxiety, antibiotics, antidepressants, probiotics, IBS
|
guest ::
